Another study, in which kininogen-deficient mutant rats were used in the coronary ligation model of MI, suggested that endogenous kinin possesses the capacity to reduce the size of MI via B2 receptor signaling due to enhanced regional myocardial blood flow around the ischemic area [177]. The gene discussed is KNG1; the disease is myocardial infarction.